Therapeutic Asset Ratings
831 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(41)
Oncolytic Measles Virus Encoding Helicobacter Pylori Neutrophil-Activating Protein
Breast Cancer
Mayo Clinic
P1
CC
(41)
Parsaclisib
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
Mayo Clinic
P1
CC
(41)
Parsaclisib
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(41)
PEGFILGRASTIM
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
Mayo Clinic
P1
CC
(41)
PEGFILGRASTIM
Indolent B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(41)
q702
Hematopoietic And Lymphoid System Neoplasm
Mayo Clinic
P1
CC
(41)
q702
Primary Central Nervous System Lymphoma
Mayo Clinic
P1
CC
(41)
q702
B-Cell Chronic Lymphocytic Leukemia
Mayo Clinic
P1
CC
(41)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Anaplastic Large Cell Lymphoma
Mayo Clinic
P1
CC
(41)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(41)
Recombinant Vesicular Stomatitis Virus-Expressing Human Interferon Beta And Sodium-Iodide Symporter
Mycosis Fungoides
Mayo Clinic
P1
CC
(41)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Anaplastic Large Cell Lymphoma
Mayo Clinic
P1
CC
(41)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(41)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Mycosis Fungoides
Mayo Clinic
P1
CC
(41)
Ruxolitinib
Anaplastic Large Cell Lymphoma
Mayo Clinic
P1
CC
(41)
Ruxolitinib
B-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(41)
Ruxolitinib
Mycosis Fungoides
Mayo Clinic
P1
CC
(41)
scd1 inhibitor mti-301
Refractory Malignant Neoplasm
Mayo Clinic
P1
CC
(41)
scd1 inhibitor mti-301
Unresectable Malignant Solid Neoplasm
Mayo Clinic
P1
CC
(41)
Sonidegib
Cutaneous Melanoma
Mayo Clinic
P1
CC
(41)
Sonidegib
Lung Cancer
Mayo Clinic
P1
CC
(41)
Sonidegib
Unresectable Malignant Solid Neoplasm
Mayo Clinic
P1
CC
(41)
wsd0922-fu
Lung Cancer
Mayo Clinic
P1
CC
(41)
FLORTAUCIPIR
Parkinson Disease
Mayo Clinic
P1
CC
(40)
Showing 726 to 750 of 831 assets
Previous
Page 30 of 34
Next
